Cargando…

Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC

Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (SCBs) can result in anxiety, psychosis, chest pain, seizures and death. To potentially explain higher toxicity associated with SCB use, we hypothesized that AB-PINACA, a common second generatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutchison, Rachel D., Ford, Benjamin M., Franks, Lirit N., Wilson, Catheryn D., Yarbrough, Azure L., Fujiwara, Ryoichi, Su, Mark K., Fernandez, Denise, James, Laura P., Moran, Jeffery H., Patton, Amy L., Fantegrossi, William E., Radominska-Pandya, Anna, Prather, Paul L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168621/
https://www.ncbi.nlm.nih.gov/pubmed/30319418
http://dx.doi.org/10.3389/fphar.2018.01084
_version_ 1783360389143068672
author Hutchison, Rachel D.
Ford, Benjamin M.
Franks, Lirit N.
Wilson, Catheryn D.
Yarbrough, Azure L.
Fujiwara, Ryoichi
Su, Mark K.
Fernandez, Denise
James, Laura P.
Moran, Jeffery H.
Patton, Amy L.
Fantegrossi, William E.
Radominska-Pandya, Anna
Prather, Paul L.
author_facet Hutchison, Rachel D.
Ford, Benjamin M.
Franks, Lirit N.
Wilson, Catheryn D.
Yarbrough, Azure L.
Fujiwara, Ryoichi
Su, Mark K.
Fernandez, Denise
James, Laura P.
Moran, Jeffery H.
Patton, Amy L.
Fantegrossi, William E.
Radominska-Pandya, Anna
Prather, Paul L.
author_sort Hutchison, Rachel D.
collection PubMed
description Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (SCBs) can result in anxiety, psychosis, chest pain, seizures and death. To potentially explain higher toxicity associated with SCB use, we hypothesized that AB-PINACA, a common second generation SCB, exhibits atypical pharmacodynamic properties at CB1 cannabinoid receptors (CB1Rs) and/or a distinct metabolic profile when compared to Δ(9)-tetrahydrocannabinol (Δ(9)-THC), the principal psychoactive cannabinoid present in marijuana. Liquid chromatography tandem mass spectrometry (LC/MS) identified AB-PINACA and monohydroxy metabolite(s) as primary phase I metabolites (4OH-AB-PINACA and/or 5OH-AB-PINACA) in human urine and serum obtained from forensic samples. In vitro experiments demonstrated that when compared to Δ(9)-THC, AB-PINACA exhibits similar affinity for CB1Rs, but greater efficacy for G-protein activation and higher potency for adenylyl cyclase inhibition. Chronic treatment with AB-PINACA also results in greater desensitization of CB1Rs (e.g., tolerance) than Δ(9)-THC. Importantly, monohydroxy metabolites of AB-PINACA retain affinity and full agonist activity at CB1Rs. Incubation of 4OH-AB-PINACA and 5OH-AB-PINACA with human liver microsomes (HLMs) results in limited glucuronide formation when compared to that of JWH-018-M2, a major monohydroxylated metabolite of the first generation SCB JWH-018. Finally, AB-PINACA and 4OH-AB-PINACA are active in vivo, producing CB1R-mediated hypothermia in mice. Taken collectively, the atypical pharmacodynamic properties of AB-PINACA at CB1Rs relative to Δ(9)-THC (e.g., higher potency/efficacy and greater production of desensitization), coupled with an unusual metabolic profile (e.g., production of metabolically stable active phase I metabolites) may contribute to the pronounced adverse effects observed with abuse of this SCB compared to marijuana.
format Online
Article
Text
id pubmed-6168621
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61686212018-10-12 Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC Hutchison, Rachel D. Ford, Benjamin M. Franks, Lirit N. Wilson, Catheryn D. Yarbrough, Azure L. Fujiwara, Ryoichi Su, Mark K. Fernandez, Denise James, Laura P. Moran, Jeffery H. Patton, Amy L. Fantegrossi, William E. Radominska-Pandya, Anna Prather, Paul L. Front Pharmacol Pharmacology Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (SCBs) can result in anxiety, psychosis, chest pain, seizures and death. To potentially explain higher toxicity associated with SCB use, we hypothesized that AB-PINACA, a common second generation SCB, exhibits atypical pharmacodynamic properties at CB1 cannabinoid receptors (CB1Rs) and/or a distinct metabolic profile when compared to Δ(9)-tetrahydrocannabinol (Δ(9)-THC), the principal psychoactive cannabinoid present in marijuana. Liquid chromatography tandem mass spectrometry (LC/MS) identified AB-PINACA and monohydroxy metabolite(s) as primary phase I metabolites (4OH-AB-PINACA and/or 5OH-AB-PINACA) in human urine and serum obtained from forensic samples. In vitro experiments demonstrated that when compared to Δ(9)-THC, AB-PINACA exhibits similar affinity for CB1Rs, but greater efficacy for G-protein activation and higher potency for adenylyl cyclase inhibition. Chronic treatment with AB-PINACA also results in greater desensitization of CB1Rs (e.g., tolerance) than Δ(9)-THC. Importantly, monohydroxy metabolites of AB-PINACA retain affinity and full agonist activity at CB1Rs. Incubation of 4OH-AB-PINACA and 5OH-AB-PINACA with human liver microsomes (HLMs) results in limited glucuronide formation when compared to that of JWH-018-M2, a major monohydroxylated metabolite of the first generation SCB JWH-018. Finally, AB-PINACA and 4OH-AB-PINACA are active in vivo, producing CB1R-mediated hypothermia in mice. Taken collectively, the atypical pharmacodynamic properties of AB-PINACA at CB1Rs relative to Δ(9)-THC (e.g., higher potency/efficacy and greater production of desensitization), coupled with an unusual metabolic profile (e.g., production of metabolically stable active phase I metabolites) may contribute to the pronounced adverse effects observed with abuse of this SCB compared to marijuana. Frontiers Media S.A. 2018-09-26 /pmc/articles/PMC6168621/ /pubmed/30319418 http://dx.doi.org/10.3389/fphar.2018.01084 Text en Copyright © 2018 Hutchison, Ford, Franks, Wilson, Yarbrough, Fujiwara, Su, Fernandez, James, Moran, Patton, Fantegrossi, Radominska-Pandya and Prather. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Hutchison, Rachel D.
Ford, Benjamin M.
Franks, Lirit N.
Wilson, Catheryn D.
Yarbrough, Azure L.
Fujiwara, Ryoichi
Su, Mark K.
Fernandez, Denise
James, Laura P.
Moran, Jeffery H.
Patton, Amy L.
Fantegrossi, William E.
Radominska-Pandya, Anna
Prather, Paul L.
Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
title Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
title_full Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
title_fullStr Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
title_full_unstemmed Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
title_short Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
title_sort atypical pharmacodynamic properties and metabolic profile of the abused synthetic cannabinoid ab-pinaca: potential contribution to pronounced adverse effects relative to δ(9)-thc
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168621/
https://www.ncbi.nlm.nih.gov/pubmed/30319418
http://dx.doi.org/10.3389/fphar.2018.01084
work_keys_str_mv AT hutchisonracheld atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT fordbenjaminm atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT franksliritn atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT wilsoncatherynd atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT yarbroughazurel atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT fujiwararyoichi atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT sumarkk atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT fernandezdenise atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT jameslaurap atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT moranjefferyh atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT pattonamyl atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT fantegrossiwilliame atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT radominskapandyaanna atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc
AT pratherpaull atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc